Smart ROS Nanoplatform Boosts Targeted Cancer Therapy
In recent years, the convergence of nanotechnology and medical science has opened new avenues for targeted therapy, leading to innovative ...
Tag: precision oncology
Pinpointing KLK3 Targets for Prostate Cancer Therapy
In a groundbreaking study published recently in Medical Oncology, researchers have unveiled a promising new strategy to combat prostate cancer ...
Groundbreaking Cancer Therapy Advances to Phase 2 Trials
A groundbreaking development in cancer therapeutics has emerged from the collaborative efforts of Georgia State University researchers and the biotech ...
Innovative Tracer Lets Surgeons Visualize and Hear Prostate Cancer
In the continuous quest to enhance precision in cancer surgeries, a groundbreaking development has emerged from the University of British ...
Huntsman Cancer Institute Leaders Propel Theranostics Innovation to Revolutionize Cancer Treatment
Huntsman Cancer Institute at the University of Utah has announced a significant advancement in its approach to cancer treatment and ...
CAR T-Cell Therapy: The Future of Cancer Eradication
In recent years, the revolutionary field of immunotherapy has drastically reshaped the landscape of cancer treatment, pushing the boundaries of ...
Tracking Tumor DNA During Gastric Cancer Treatment
In the rapidly evolving field of oncology, the pursuit of non-invasive biomarkers that can dynamically track tumor evolution during treatment ...
New Organ Chip Platform for Precision Oncology Predicts Chemotherapy Responses in Esophageal Adenocarcinoma Patients
Esophageal adenocarcinoma (EAC) represents one of the most formidable challenges in modern oncology, recognized as the sixth leading cause of ...
![PD-L1 targeting molecular imaging in head and neck carcinoma: A head-to-head comparison of [18F]AlF-NOTA-PCP2 PET and [18F]FDG PET/CT.](https://bioengineer.org/wp-content/uploads/2025/06/SNMMI-Image-of-the-Year-Novel-Immuno-PET-Tracer-Outperforms-FDG-350x250.jpeg)
SNMMI Image of the Year: Novel Immuno-PET Tracer Outperforms FDG PET in Predicting PD-L1 Expression in Head and Neck Cancer
A groundbreaking advancement in molecular imaging has recently emerged from the realm of nuclear medicine, promising to redefine how clinicians ...
New Test Developed to Predict Patient Resistance to Cancer Chemotherapy
In a groundbreaking advancement poised to revolutionize oncological treatment, scientists at the Spanish National Cancer Research Centre (CNIO) have unveiled ...
Tracking Cancer Drug Resistance Using Genetic Barcoding
In the relentless battle against cancer, understanding how tumors evolve to resist treatment remains one of the most formidable challenges ...
CircSLC22A3 Blocks ESCC Spread via m6A Pathway
In a groundbreaking study published in BMC Cancer, researchers unveil the pivotal role of a circular RNA, circSLC22A3, in suppressing ...
Pan-Cancer Study Reveals DNA Repair Defects
A groundbreaking pan-cancer study published in BMC Cancer unveils the intricate landscape of homologous recombination deficiency (HRD) and homologous recombination ...
Ahead-of-Print Highlights from The Journal of Nuclear Medicine – April 18, 2025
Reston, VA (April 18, 2025)—In a series of breakthrough developments, The Journal of Nuclear Medicine (JNM) has unveiled pioneering research ...
New Insights into FOXR2 Activation Across Brain Tumors Enhance Diagnostic Precision and Patient Care
In a groundbreaking development that challenges established conventions in neuro-oncology, researchers at St. Jude Children’s Research Hospital have unveiled compelling ...
POPULAR NEWS
-
Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges
-
Physicists Develop Visible Time Crystal for the First Time
-
Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases
-
Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation